{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:08:30Z","timestamp":1773212910439,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00292-019-00682-x","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T15:35:55Z","timestamp":1573227355000},"page":"369-372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prim\u00e4rer Hyperaldosteronismus","Primary aldosteronism"],"prefix":"10.1007","volume":"40","author":[{"given":"U.","family":"Scholl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,8]]},"reference":[{"key":"682_CR1","doi-asserted-by":"publisher","first-page":"e41926","DOI":"10.1371\/journal.pone.0041926","volume":"7","author":"T Akerstrom","year":"2012","unstructured":"Akerstrom\u00a0T, Crona\u00a0J, Delgado Verdugo\u00a0A et al (2012) Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. Plos One 7:e41926","journal-title":"Plos One"},{"key":"682_CR2","doi-asserted-by":"publisher","first-page":"19546","DOI":"10.1038\/srep19546","volume":"6","author":"T Akerstrom","year":"2016","unstructured":"Akerstrom\u00a0T, Maharjan\u00a0R, Willenberg\u00a0SH et\u00a0al (2016) Activating mutations in CTNNB1 in aldosterone producing adenomas. Sci Rep 6:19546","journal-title":"Sci Rep"},{"key":"682_CR3","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/ng.2716","volume":"45","author":"EA Azizan","year":"2013","unstructured":"Azizan\u00a0EA, Poulsen\u00a0H, Tuluc\u00a0P et\u00a0al (2013) Somatic mutations in ATP1A1 and CACNA1D underlie a\u00a0common subtype of adrenal hypertension. Nat Genet 45:1055\u20131060","journal-title":"Nat Genet"},{"key":"682_CR4","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ng.2550","volume":"45","author":"F Beuschlein","year":"2013","unstructured":"Beuschlein\u00a0F, Boulkroun\u00a0S, Osswald\u00a0A et al (2013) Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension. Nat Genet 45:440\u2013444","journal-title":"Nat Genet"},{"key":"682_CR5","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1198785","volume":"331","author":"M Choi","year":"2011","unstructured":"Choi\u00a0M, Scholl\u00a0UI, Yue\u00a0P et al (2011) K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science 331:768\u2013772","journal-title":"Science"},{"key":"682_CR6","first-page":"3","volume":"45","author":"JW Conn","year":"1955","unstructured":"Conn\u00a0JW (1955) Presidential address. I. Painting background. II. Primary aldosteronism, a\u00a0new clinical syndrome. J\u00a0Lab Clin Med 45:3\u201317","journal-title":"J Lab Clin Med"},{"key":"682_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41588-018-0053-8","volume":"50","author":"FL Fernandes-Rosa","year":"2018","unstructured":"Fernandes-Rosa\u00a0FL, Daniil\u00a0G, Orozco\u00a0IJ et al (2018) A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism. Nat Genet 50:355\u2013361","journal-title":"Nat Genet"},{"key":"682_CR8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","volume":"64","author":"FL Fernandes-Rosa","year":"2014","unstructured":"Fernandes-Rosa\u00a0FL, Williams\u00a0TA, Riester\u00a0A et al (2014) Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma. Hypertension 64:354\u2013361","journal-title":"Hypertension"},{"key":"682_CR9","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder\u00a0JW, Carey\u00a0RM, Mantero\u00a0F et\u00a0al (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J\u00a0Clin Endocrinol Metab 101:1889\u20131916","journal-title":"J Clin Endocrinol Metab"},{"key":"682_CR10","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1161\/HYPERTENSIONAHA.115.05873","volume":"66","author":"F Gioco","year":"2015","unstructured":"Gioco\u00a0F, Seccia\u00a0TM, Gomez-Sanchez\u00a0EP et al (2015) Adrenal histopathology in primary aldosteronism: is it time for a\u00a0change? Hypertension 66:724\u2013730","journal-title":"Hypertension"},{"key":"682_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/ng.2956","volume":"46","author":"G Goh","year":"2014","unstructured":"Goh\u00a0G, Scholl\u00a0UI, Healy\u00a0JM et al (2014) Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors. Nat Genet 46:613\u2013617","journal-title":"Nat Genet"},{"key":"682_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/355262a0","volume":"355","author":"RP Lifton","year":"1992","unstructured":"Lifton\u00a0RP, Dluhy\u00a0RG, Powers\u00a0M et al (1992) A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262\u2013265","journal-title":"Nature"},{"key":"682_CR13","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez\u00a0P, Girerd\u00a0X, Plouin\u00a0PF et\u00a0al (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J\u00a0Am Coll Cardiol 45:1243\u20131248","journal-title":"J Am Coll Cardiol"},{"key":"682_CR14","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone\u00a0S, Burrello\u00a0J, Tizzani\u00a0D et\u00a0al (2017) Prevalence and clinical manifestations of primary Aldosteronism encountered in primary care practice. J\u00a0Am Coll Cardiol 69:1811\u20131820","journal-title":"J Am Coll Cardiol"},{"key":"682_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","volume":"6","author":"S Monticone","year":"2018","unstructured":"Monticone\u00a0S, D\u2019ascenzo\u00a0F, Moretti\u00a0C et al (2018) Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a\u00a0systematic review and meta-analysis. Lancet Diabetes Endocrinol 6:41\u201350","journal-title":"Lancet Diabetes Endocrinol"},{"key":"682_CR16","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1210\/jc.2018-01004","volume":"103","author":"K Nanba","year":"2018","unstructured":"Nanba\u00a0K, Omata\u00a0K, Else\u00a0T et al (2018) Targeted molecular characterization of aldosterone-producing adenomas in white Americans. J\u00a0Clin Endocrinol Metab 103:3869\u20133876","journal-title":"J Clin Endocrinol Metab"},{"key":"682_CR17","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","volume":"73","author":"K Nanba","year":"2019","unstructured":"Nanba\u00a0K, Omata\u00a0K, Gomez-Sanchez\u00a0CE et al (2019) Genetic characteristics of aldosterone-producing adenomas in blacks. Hypertension 73:885\u2013892","journal-title":"Hypertension"},{"key":"682_CR18","doi-asserted-by":"publisher","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","volume":"112","author":"K Nishimoto","year":"2015","unstructured":"Nishimoto\u00a0K, Tomlins\u00a0SA, Kuick\u00a0R et al (2015) Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands. Proc Natl Acad Sci U S\u00a0A 112:E4591\u2013E4599","journal-title":"Proc Natl Acad Sci U S A"},{"key":"682_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/HYPERTENSIONAHA.117.10263","volume":"71","author":"Y Ohno","year":"2018","unstructured":"Ohno\u00a0Y, Sone\u00a0M, Inagaki\u00a0N et\u00a0al (2018) Prevalence of cardiovascular disease and its risk factors in primary aldosteronism: a multicenter study in Japan. Hypertension 71:530\u2013537","journal-title":"Hypertension"},{"key":"682_CR20","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","volume":"72","author":"K Omata","year":"2018","unstructured":"Omata\u00a0K, Satoh\u00a0F, Morimoto\u00a0R et\u00a0al (2018) Cellular and genetic causes of idiopathic hyperaldosteronism. Hypertension 72:874\u2013880","journal-title":"Hypertension"},{"key":"682_CR21","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi\u00a0GP, Bernini\u00a0G, Caliumi\u00a0C et\u00a0al (2006) A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J\u00a0Am Coll Cardiol 48:2293\u20132300","journal-title":"J Am Coll Cardiol"},{"key":"682_CR22","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/ng.2695","volume":"45","author":"UI Scholl","year":"2013","unstructured":"Scholl\u00a0UI, Goh\u00a0G, Stolting\u00a0G et al (2013) Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism. Nat Genet 45:1050\u20131054","journal-title":"Nat Genet"},{"key":"682_CR23","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/cen.12873","volume":"83","author":"UI Scholl","year":"2015","unstructured":"Scholl\u00a0UI, Healy\u00a0JM, Thiel\u00a0A et\u00a0al (2015) Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype. Clin Endocrinol 83:779\u2013789","journal-title":"Clin Endocrinol"},{"key":"682_CR24","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1073\/pnas.1121407109","volume":"109","author":"UI Scholl","year":"2012","unstructured":"Scholl\u00a0UI, Nelson-Williams\u00a0C, Yue\u00a0P et al (2012) Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc Natl Acad Sci U S\u00a0A 109:2533\u20132538","journal-title":"Proc Natl Acad Sci U S A"},{"key":"682_CR25","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.06315","author":"UI Scholl","year":"2015","unstructured":"Scholl\u00a0UI, Stolting\u00a0G, Nelson-Williams\u00a0C et al (2015) Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. Elife. https:\/\/doi.org\/10.7554\/eLife.06315","journal-title":"Elife"},{"key":"682_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","volume":"50","author":"UI Scholl","year":"2018","unstructured":"Scholl\u00a0UI, Stolting\u00a0G, Schewe\u00a0J et\u00a0al (2018) CLCN2 chloride channel mutations in familial hyperaldosteronism type II. Nat Genet 50:349\u2013354","journal-title":"Nat Genet"},{"key":"682_CR27","first-page":"1109","volume":"95","author":"DJ Sutherland","year":"1966","unstructured":"Sutherland\u00a0DJ, Ruse\u00a0JL, Laidlaw\u00a0JC (1966) Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc\u00a0J 95:1109\u20131119","journal-title":"Can Med Assoc J"},{"key":"682_CR28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2265.2007.03033.x","volume":"68","author":"M Tadjine","year":"2008","unstructured":"Tadjine\u00a0M, Lampron\u00a0A, Ouadi\u00a0L et al (2008) Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas. Clin Endocrinol 68:264\u2013270","journal-title":"Clin Endocrinol"},{"key":"682_CR29","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1210\/jc.2011-2885","volume":"97","author":"R Taguchi","year":"2012","unstructured":"Taguchi\u00a0R, Yamada\u00a0M, Nakajima\u00a0Y et al (2012) Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J\u00a0Clin Endocrinol Metab 97:1311\u20131319","journal-title":"J Clin Endocrinol Metab"},{"key":"682_CR30","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","volume":"65","author":"FF Zheng","year":"2015","unstructured":"Zheng\u00a0FF, Zhu\u00a0LM, Nie\u00a0AF et al (2015) Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma. Hypertension 65:622\u2013628","journal-title":"Hypertension"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-019-00682-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-019-00682-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-019-00682-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T15:26:00Z","timestamp":1722007560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-019-00682-x"}},"subtitle":["Genetik und Pathologie","Genetics and pathology"],"short-title":[],"issued":{"date-parts":[[2019,11,8]]},"references-count":30,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1007\/s00292-019-00682-x","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,8]]},"assertion":[{"value":"8 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"U.\u00a0Scholl gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}